Multifunctional polymeric micelles for delivery of drugs and siRNA

Frontiers in Pharmacology

Volumn 5 APR, Issue , 2014, Pages

  Jhaveri, Aditi M ^a   Torchilin, Vladimir P ^a  

^a NORTHEASTERN UNIVERSITY   (United States)

Author keywords

Micelles; Multifunctional; Nanocarriers; Polymeric; SiRNA; Targeted

Indexed keywords

APTAMER; CISPLATIN; COPOLYMER; CURCUMIN; DOCETAXEL; DOXORUBICIN; ELACRIDAR; FIRTECAN; MACROGOL; MIRIPLATIN; PACLITAXEL; POLY(N ISOPROPYLACRYLAMIDE); POVIDONE; SMALL INTERFERING RNA;

BIOCOMPATIBILITY; CANCER GENE THERAPY; DRUG DELIVERY SYSTEM; DRUG PENETRATION; DRUG RELEASE; DRUG STABILITY; DRUG TARGETING; GENE DELIVERY SYSTEM; HUMAN; LASER MICROSCOPY; LONGEVITY; MICELLE; NONHUMAN; POLYMERIC MICELLE; PROTEIN TARGETING; REVIEW; TUMOR MICROENVIRONMENT; TUMOR VASCULARIZATION;

EID: 84901030049     PISSN: None     EISSN: 16639812     Source Type: Journal    
DOI: 10.3389/fphar.2014.00077     Document Type: Review

References (257)

1. Abouzeid, A. H., Patel, N. R., Rachman, I. M., Senn, S., and Torchilin, V. P. (2013). Anti-cancer activity of anti-GLUT1 antibody-targeted polymeric micelles co-loaded with curcumin and doxorubicin. J. Drug Target. 21, 994-1000. doi: 10.3109/1061186X.2013.840639
2. Abouzeid, A. H., Patel, N. R., and Torchilin, V. P. (2014). Polyethylene glycol-phosphatidylethanolamine (PEG-PE)/vitamin E micelles for co-delivery of paclitaxel and curcumin to overcome multi-drug resistance in ovarian cancer. Int. J. Pharm. 464, 178-184. doi: 10.1016/j.ijpharm.2014.01.009
3. Ai, J., Biazar, E., Jafarpour, M., Montazeri, M., Majdi, A., Aminifard, S., et al. (2011). Nanotoxicology and nanoparticle safety in biomedical designs. Int. J. Nanomedicine 6, 1117-1127. doi: 10.2147/IJN.S16603
4. Allen, T. M., and Cullis, P. R. (2004). Drug delivery systems: entering the mainstream. Science 303, 1818-1822. doi: 10.1126/science.1095833
5. Bailly, N., Thomas, M., and Klumperman, B. (2012). Poly(N-vinylpyrrolidone)-block-poly(vinyl acetate) as a drug delivery vehicle for hydrophobic drugs. Biomacromolecules 13, 4109-4117. doi: 10.1021/bm301410d
6. Bastakoti, B. P., Wu, K. C., Inoue, M., Yusa, S., Nakashima, K., and Yamauchi, Y. (2013). Multifunctional core-shell-corona-type polymeric micelles for anticancer drug-delivery and imaging. Chemistry 19, 4812-4817. doi: 10.1002/chem.201203958
7. Benoit, D. S., Henry, S. M., Shubin, A. D., Hoffman, A. S., and Stayton, P. S. (2010). pH-responsive polymeric sirna carriers sensitize multidrug resistant ovarian cancer cells to doxorubicin via knockdown of polo-like kinase 1. Mol. Pharm. 7, 442-455. doi: 10.1021/mp9002255
8. Blanco, E., Kessinger, C. W., Sumer, B. D., and Gao, J. (2009). Multifunctional micellar nanomedicine for cancer therapy. Exp. Biol. Med. 234, 123-131. doi: 10.3181/0808-MR-250
9. Boissiere, O., Han, D., Tremblay, L., and Zhao, Y. (2011). Flower micelles of poly(N-isopropylacrylamide) with azobenzene moieties regularly inserted into the main chain. Soft Matter 7, 9410-9415. doi: 10.1039/c1sm06149f
10. Bumcrot, D., Manoharan, M., Koteliansky, V., and Sah, D. W. (2006). RNAi therapeutics: a potential new class of pharmaceutical drugs. Nat. Chem. Biol. 2, 711-719. doi: 10.1038/nchembio839
11. Cabral, H., Nishiyama, N., and Kataoka, K. (2007). Optimization of (1,2-diamino-cyclohexane)platinum(II)-loaded polymeric micelles directed to improved tumor targeting and enhanced antitumor activity. J. Control. Release 121, 146-155. doi: 10.1016/j.jconrel.2007.05.024
12. Cabral, H., Nishiyama, N., Okazaki, S., Koyama, H., and Kataoka, K. (2005). Preparation and biological properties of dichloro(1,2-diaminocyclohexane)platinum(II) (DACHPt)-loaded polymeric micelles. J. Control. Release 101, 223-232. doi: 10.1016/j.jconrel.2004.08.022
13. Cao, J., Huang, S., Chen, Y., Li, S., Li, X., Deng, D., et al. (2013). Near-infrared light-triggered micelles for fast controlled drug release in deep tissue. Biomaterials 34, 6272-6283. doi: 10.1016/j.biomaterials.2013.05.008
14. Cao, N., Cheng, D., Zou, S., Ai, H., Gao, J., and Shuai, X. (2011). The synergistic effect of hierarchical assemblies of siRNA and chemotherapeutic drugs co-delivered into hepatic cancer cells. Biomaterials 32, 2222-2232. doi: 10.1016/j.biomaterials.2010.11.061
15. Casey, J. R., Grinstein, S., and Orlowski, J. (2010). Sensors and regulators of intracellular pH. Nat. Rev. Mol. Cell Biol. 11, 50-61. doi: 10.1038/nrm2820
16. Chen, W., Zhong, P., Meng, F., Cheng, R., Deng, C., Feijen, J., et al. (2013). Redox and pH-responsive degradable micelles for dually activated intracellular anticancer drug release. J. Control. Release 169, 171-179. doi: 10.1016/j.jconrel.2013.01.001
17. Chen, Y. C., Liang, H. D., Zhang, Q. P., Blomley, M. J., and Lu, Q. L. (2006). Pluronic block copolymers: novel functions in ultrasound-mediated gene transfer and against cell damage. Ultrasound Med. Biol. 32, 131-137. doi: 10.1016/j.ultrasmedbio.2005.10.002
18. Chen, Z., He, Y., Wang, Y., and Wang, X. (2011). Amphiphilic diblock copolymer with dithienylethene pendants: synthesis and photo-modulated self-assembly. Macromol. Rapid Commun. 32, 977-982. doi: 10.1002/marc.201100142
19. Cheng, D., Cao, N., Chen, J., Yu, X., and Shuai, X. (2012). Multifunctional nanocarrier mediated co-delivery of doxorubicin and siRNA for synergistic enhancement of glioma apoptosis in rat. Biomaterials 33, 1170-1179. doi: 10.1016/j.biomaterials.2011.10.057
20. Cheng, R., Meng, F., Deng, C., Klok, H. A., and Zhong, Z. (2013). Dual and multi-stimuli responsive polymeric nanoparticles for programmed site-specific drug delivery. Biomaterials 34, 3647-3657. doi: 10.1016/j.biomaterials.2013.01.084
21. Chitkara, D., Mittal, A., Behrman, S. W., Kumar, N., and Mahato, R. I. (2013). Self-assembling, amphiphilic polymer-gemcitabine conjugate shows enhanced antitumor efficacy against human pancreatic adenocarcinoma. Bioconjug. Chem. 24, 1161-1173. doi: 10.1021/bc400032x
22. Choi, S. W., Lee, S. H., Mok, H., and Park, T. G. (2010). Multifunctional siRNA delivery system: polyelectrolyte complex micelles of six-arm PEG conjugate of siRNA and cell penetrating peptide with crosslinked fusogenic peptide. Biotechnol. Prog. 26, 57-63. doi: 10.1002/btpr.310.
23. Christie, R. J., Matsumoto, Y., Miyata, K., Nomoto, T., Fukushima, S., Osada, K., et al. (2012). Targeted polymeric micelles for siRNA treatment of experimental cancer by intravenous injection. ACS Nano 6, 5174-5189. doi: 10.1021/nn300942b
24. Chung, E. J., Cheng, Y., Morshed, R., Nord, K., Han, Y., Wegscheid, M. L., et al. (2014). Fibrin-binding, peptide amphiphile micelles for targeting glioblastoma. Biomaterials 35, 1249-1256. doi: 10.1016/j.biomaterials.2013.10.064
25. Croy, S. R., and Kwon, G. S. (2006). Polymeric micelles for drug delivery. Curr. Pharm. Des. 12, 4669-4684. doi: 10.2174/138161206779026245
26. Dagar, A., Kuzmis, A., Rubinstein, I., Sekosan, M., and Onyuksel, H. (2012). VIP-targeted cytotoxic nanomedicine for breast cancer. Drug Deliv. Transl. Res. 2, 454-462. doi: 10.1007/s13346-012-0107-x
27. Daka, A., and Peer, D. (2012). RNAi-based nanomedicines for targeted personalized therapy. Adv. Drug Deliv. Rev. 64, 1508-1521. doi: 10.1016/j.addr.2012.08.014
28. Danhier, F., Feron, O., and Preat, V. (2010). To exploit the tumor microenvironment: passive and active tumor targeting of nanocarriers for anti-cancer drug delivery. J. Control. Release 148, 135-146. doi: 10.1016/j.jconrel.2010.08.027
29. Danson, S., Ferry, D., Alakhov, V., Margison, J., Kerr, D., Jowle, D., et al. (2004). Phase I dose escalation and pharmacokinetic study of pluronic polymer-bound doxorubicin (SP1049C) in patients with advanced cancer. Br. J. Cancer 90, 2085-2091. doi: 10.1038/sj.bjc.6601856
30. Decuzzi, P., and Ferrari, M. (2008). The receptor-mediated endocytosis of nonspherical particles. Biophys. J. 94, 3790-3797. doi: 10.1529/biophysj.107.120238
31. De La Rica, R., Aili, D., and Stevens, M. M. (2012). Enzyme-responsive nanoparticles for drug release and diagnostics. Adv. Drug Deliv. Rev. 64, 967-978. doi: 10.1016/j.addr.2012.01.002
32. Desale, S. S., Cohen, S. M., Zhao, Y., Kabanov, A. V., and Bronich, T. K. (2013). Biodegradable hybrid polymer micelles for combination drug therapy in ovarian cancer. J. Control. Release 171, 339-348. doi: 10.1016/j.jconrel.2013.04.026
33. Di, L., Fish, P. V., and Mano, T. (2012). Bridging solubility between drug discovery and development. Drug Discov. Today 17, 486-495. doi: 10.1016/j.drudis.2011.11.007
34. Di, L., Kerns, E. H., and Carter, G. T. (2009). Drug-like property concepts in pharmaceutical design. Curr. Pharm. Des. 15, 2184-2194. doi: 10.2174/138161209788682479
35. Dimitrov, I., Trzebicka, B., Müller, A. H. E., Dworak, A., and Tsvetanov, C. B. (2007). Thermosensitive water-soluble copolymers with doubly responsive reversibly interacting entities. Prog. Polym. Sci. 32, 1275-1343. doi: 10.1016/j.progpolymsci.2007.07.001
36. Ding, M., Song, N., He, X., Li, J., Zhou, L., Tan, H., et al. (2013). Toward the next-generation nanomedicines: design of multifunctional multiblock polyurethanes for effective cancer treatment. ACS Nano 7, 1918-1928. doi: 10.1021/nn4002769
37. Dominska, M., and Dykxhoorn, D. M. (2010). Breaking down the barriers: siRNA delivery and endosome escape. J. Cell Sci. 123, 1183-1189. doi: 10.1242/jcs.066399
38. Du, Y. Z., Weng, Q., Yuan, H., and Hu, F. Q. (2010). Synthesis and antitumor activity of stearate-g-dextran micelles for intracellular doxorubicin delivery. ACS Nano 4, 6894-6902. doi: 10.1021/nn100927t
39. Duncan, R., and Gaspar, R. (2011). Nanomedicine(s) under the microscope. Mol. Pharm. 8, 2101-2141. doi: 10.1021/mp200394t
40. Duong, H. H., and Yung, L. Y. (2013). Synergistic co-delivery of doxorubicin and paclitaxel using multi-functional micelles for cancer treatment. Int. J. Pharm. 454, 486-495. doi: 10.1016/j.ijpharm.2013.06.017
41. Elbashir, S. M., Harborth, J., Lendeckel, W., Yalcin, A., Weber, K., and Tuschl, T. (2001). Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells. Nature 411, 494-498. doi: 10.1038/35078107
42. Elsabahy, M., Wazen, N., Bayó-Puxan, N., Deleavey, G., Servant, M., Damha, M. J., et al. (2009). Delivery of nucleic acids through the controlled disassembly of multifunctional nanocomplexes. Adv. Funct. Mater. 19, 3862-3867. doi: 10.1002/adfm.200901139
43. Elsaesser, A., and Howard, C. V. (2012). Toxicology of nanoparticles. Adv. Drug Deliv. Rev. 64, 129-137. doi: 10.1016/j.addr.2011.09.001
44. Falamarzian, A., Xiong, X.-B., Uludag, H., and Lavasanifar, A. (2012). Polymeric micelles for siRNA delivery. J. Drug Deliv. Sci. Technol. 22, 43-54.
45. Fang, J., Nakamura, H., and Maeda, H. (2011). The EPR effect: unique features of tumor blood vessels for drug delivery, factors involved, and limitations and augmentation of the effect. Adv. Drug Deliv. Rev. 63, 136-151. doi: 10.1016/j.addr.2010.04.009
46. Felber, A. E., Castagner, B., Elsabahy, M., Deleavey, G. F., Damha, M. J., and Leroux, J. C. (2011). siRNA nanocarriers based on methacrylic acid copolymers. J. Control. Release 152, 159-167. doi: 10.1016/j.jconrel.2010.12.012
47. Felber, A. E., Dufresne, M. H., and Leroux, J. C. (2012). pH-sensitive vesicles, polymeric micelles, and nanospheres prepared with polycarboxylates. Adv. Drug Deliv. Rev. 64, 979-992. doi: 10.1016/j.addr.2011.09.006
48. Fernandez, A. M., Van Derpoorten, K., Dasnois, L., Lebtahi, K., Dubois, V., Lobl, T. J., et al. (2001). N-Succinyl-(beta-alanyl-L-leucyl-L-alanyl-L-leucyl)doxorubicin: an extracellularly tumor-activated prodrug devoid of intravenous acute toxicity. J. Med. Chem. 44, 3750-3753. doi: 10.1021/jm0108754
49. Fire, A., Xu, S. Q., Montgomery, M. K., Kostas, S. A., Driver, S. E., and Mello, C. C. (1998). Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans. Nature 391, 806-811. doi: 10.1038/35888
50. Firer, M. A., and Gellerman, G. (2012). Targeted drug delivery for cancer therapy: the other side of antibodies. J. Hematol. Oncol. 5:70. doi: 10.1186/1756-8722-5-70
51. Fleige, E., Quadir, M. A., and Haag, R. (2012). Stimuli-responsive polymeric nanocarriers for the controlled transport of active compounds: concepts and applications. Adv. Drug Deliv. Rev. 64, 866-884. doi: 10.1016/j.addr.2012.01.020
52. Folkman, J. (1995). Angiogenesis in cancer, vascular, rheumatoid and other disease. Nat. Med. 1, 27-31. doi: 10.1038/nm0195-27
53. Fomina, N., Sankaranarayanan, J., and Almutairi, A. (2012). Photochemical mechanisms of light-triggered release from nanocarriers. Adv. Drug Deliv. Rev. 64, 1005-1020. doi: 10.1016/j.addr.2012.02.006
54. Fonge, H., Huang, H., Scollard, D., Reilly, R. M., and Allen, C. (2012). Influence of formulation variables on the biodistribution of multifunctional block copolymer micelles. J. Control. Release 157, 366-374. doi: 10.1016/j.jconrel.2011.09.088
55. Freichels, H., Alaimo, D., Auzely-Velty, R., and Jerome, C. (2012). alpha-Acetal, omega-alkyne poly(ethylene oxide) as a versatile building block for the synthesis of glycoconjugated graft-copolymers suited for targeted drug delivery. Bioconjug. Chem. 23, 1740-1752. doi: 10.1021/bc200650n
56. Ganta, S., Devalapally, H., Shahiwala, A., and Amiji, M. (2008). A review of stimuli-responsive nanocarriers for drug and gene delivery. J. Control. Release 126, 187-204. doi: 10.1016/j.jconrel.2007.12.017
57. Gerweck, L. E., and Seetharaman, K. (1996). Cellular pH gradient in tumor versus normal tissue: potential exploitation for the treatment of cancer. Cancer Res. 56, 1194-1198.
58. Glover, A. L., Bennett, J. B., Pritchett, J. S., Nikles, S. M., Nikles, D. E., Nikles, J. A., et al. (2013). Magnetic heating of iron oxide nanoparticles and magnetic micelles for cancer therapy. IEEE Trans. Magn. 49, 231-235. doi: 10.1109/TMAG.2012.2222359
59. Gohy, J. F., and Zhao, Y. (2013). Photo-responsive block copolymer micelles: design and behavior. Chem. Soc. Rev. 42, 7117-7129. doi: 10.1039/c3cs35469e
60. Goldenberg, D. M., and Sharkey, R. M. (2012). Using antibodies to target cancer therapeutics. Expert Opin. Biol. Ther. 12, 1173-1190. doi: 10.1517/14712598.2012.693472
61. Gülçür, E., Thaqi, M., Khaja, F., Kuzmis, A., and Önyüksel, H. (2013). Curcumin in VIP-targeted sterically stabilized phospholipid nanomicelles: a novel therapeutic approach for breast cancer and breast cancer stem cells. Drug Deliv. Transl. Res. 3, 562-574. doi: 10.1007/s13346-013-0167-6
62. Guo, J., Hong, H., Chen, G., Shi, S., Zheng, Q., Zhang, Y., et al. (2013). Image-guided and tumor-targeted drug delivery with radiolabeled unimolecular micelles. Biomaterials 34, 8323-8332. doi: 10.1016/j.biomaterials.2013.07.085
63. Hamaguchi, T., Kato, K., Yasui, H., Morizane, C., Ikeda, M., Ueno, H., et al. (2007). A phase I and pharmacokinetic study of NK105, a paclitaxel-incorporating micellar nanoparticle formulation. Br. J. Cancer 97, 170-176. doi: 10.1038/sj.bjc.6603855
64. Hami, Z., Amini, M., Ghazi-Khansari, M., Rezayat, S. M., and Gilani, K. (2014). Synthesis and in vitro evaluation of a pH-sensitive PLA-PEG-folate based polymeric micelle for controlled delivery of docetaxel. Colloids Surf. B Biointerfaces 116C, 309-317. doi: 10.1016/j.colsurfb.2014.01.015
65. Hannon, G. J. (2002). RNA interference. Nature 418, 244-251. doi: 10.1038/418244a
66. Hatakeyama, H., Akita, H., and Harashima, H. (2011). A multifunctional envelope type nano device (MEND) for gene delivery to tumours based on the EPR effect: a strategy for overcoming the PEG dilemma. Adv. Drug Deliv. Rev. 63, 152-160. doi: 10.1016/j.addr.2010.09.001
67. Hoang, B., Ekdawi, S. N., Reilly, R. M., and Allen, C. (2013). Active targeting of block copolymer micelles with trastuzumab fab fragments and nuclear localization signal leads to increased tumor uptake and nuclear localization in HER2-overexpressing xenografts. Mol. Pharm. 10, 4229-4241. doi: 10.1021/mp400315p
68. Hobbs, S. K., Monsky, W. L., Yuan, F., Roberts, W. G., Griffith, L., Torchilin, V. P., et al. (1998). Regulation of transport pathways in tumor vessels: role of tumor type and microenvironment. Proc. Natl. Acad. Sci. U.S.A. 95, 4607-4612. doi: 10.1073/pnas.95.8.4607
69. Holliger, P., and Hudson, P. J. (2005). Engineered antibody fragments and the rise of single domains. Nat. Biotechnol. 23, 1126-1136. doi: 10.1038/nbt1142
70. Hossain, M. D. D., Tran, L. T. B., Park, J. M., and Lim, K. T. (2010). Facile synthesis of core-surface crosslinked nanoparticles by interblock RAFT polymerization. J. Polym. Sci. A Polym. Chem. 48, 4958-4964. doi: 10.1002/pola.24291
71. Howell, M., Mallela, J., Wang, C., Ravi, S., Dixit, S., Garapati, U., et al. (2013). Manganese-loaded lipid-micellar theranostics for simultaneous drug and gene delivery to lungs. J. Control. Release 167, 210-218. doi: 10.1016/j.jconrel.2013.01.029
72. Hu, J., Zhang, G., and Liu, S. (2012). Enzyme-responsive polymeric assemblies, nanoparticles and hydrogels. Chem. Soc. Rev. 41, 5933-5949. doi: 10.1039/c2cs35103j
73. Huang, C., Tang, Z., Zhou, Y., Zhou, X., Jin, Y., Li, D., et al. (2012). Magnetic micelles as a potential platform for dual targeted drug delivery in cancer therapy. Int. J. Pharm. 429, 113-122. doi: 10.1016/j.ijpharm.2012.03.001
74. Husseini, G. A., and Pitt, W. G. (2008a). Micelles and nanoparticles for ultrasonic drug and gene delivery. Adv. Drug Deliv. Rev. 60, 1137-1152. doi: 10.1016/j.addr.2008.03.008
75. Husseini, G. A., and Pitt, W. G. (2008b). The use of ultrasound and micelles in cancer treatment. J. Nanosci. Nanotechnol. 8, 2205-2215. doi: 10.1166/jnn.2008.225
76. Husseini, G. A., Pitt, W. G., Christensen, D. A., and Dickinson, D. J. (2009). Degradation kinetics of stabilized Pluronic micelles under the action of ultrasound. J. Control. Release 138, 45-48. doi: 10.1016/j.jconrel.2009.04.018
77. Husseini, G. A., Velluto, D., Kherbeck, L., Pitt, W. G., Hubbell, J. A., and Christensen, D. A. (2013). Investigating the acoustic release of doxorubicin from targeted micelles. Colloids Surf. B Biointerfaces 101, 153-155. doi: 10.1016/j.colsurfb.2012.05.025
78. Iyer, A. K., Khaled, G., Fang, J., and Maeda, H. (2006). Exploiting the enhanced permeability and retention effect for tumor targeting. Drug Discov. Today 11, 812-818. doi: 10.1016/j.drudis.2006.07.005
79. Jabr-Milane, L. S., Van Vlerken, L. E., Yadav, S., and Amiji, M. M. (2008). Multi-functional nanocarriers to overcome tumor drug resistance. Cancer Treat. Rev. 34, 592-602. doi: 10.1016/j.ctrv.2008.04.003
80. Jain, R. K. (1987). Transport of molecules across tumor vasculature. Cancer Metastasis Rev. 6, 559-593. doi: 10.1007/BF00047468
81. Jin, C., Yang, W., Bai, L., Wang, J., and Dou, K. (2011a). Preparation and characterization of targeted DOX-PLGA-PEG micelles decorated with bivalent fragment HAb18 F(ab')2 for treatment of hepatocellular carcinoma. J. Control. Release 152(Suppl. 1), e14-e15. doi: 10.1016/j.jconrel.2011.08.093
82. Jin, Q., Mitschang, F., and Agarwal, S. (2011b). Biocompatible drug delivery system for photo-triggered controlled release of 5-Fluorouracil. Biomacromolecules 12, 3684-3691. doi: 10.1021/bm2009125
83. Jones, M., and Leroux, J. (1999). Polymeric micelles-a new generation of colloidal drug carriers. Eur. J. Pharm. Biopharm. 48, 101-111. doi: 10.1016/S0939-6411(99)00039-9
84. Kabanov, A. V., Batrakova, E. V., and Alakhov, V. Y. (2002). Pluronic block copolymers as novel polymer therapeutics for drug and gene delivery. J. Control. Release 82, 189-212. doi: 10.1016/S0168-3659(02)00009-3
85. Kagaya, H., Oba, M., Miura, Y., Koyama, H., Ishii, T., Shimada, T., et al. (2012). Impact of polyplex micelles installed with cyclic RGD peptide as ligand on gene delivery to vascular lesions. Gene Ther. 19, 61-69. doi: 10.1038/gt.2011.74
86. Kamaly, N., Xiao, Z., Valencia, P. M., Radovic-Moreno, A. F., and Farokhzad, O. C. (2012). Targeted polymeric therapeutic nanoparticles: design, development and clinical translation. Chem. Soc. Rev. 41, 2971-3010. doi: 10.1039/c2cs15344k
87. Kanasty, R., Dorkin, J. R., Vegas, A., and Anderson, D. (2013). Delivery materials for siRNA therapeutics. Nat. Mater. 12, 967-977. doi: 10.1038/nmat3765
88. Kanasty, R. L., Whitehead, K. A., Vegas, A. J., and Anderson, D. G. (2012). Action and reaction: the biological response to siRNA and its delivery vehicles. Mol. Ther. 20, 513-524. doi: 10.1038/mt.2011.294
89. Kanazawa, T., Akiyama, F., Kakizaki, S., Takashima, Y., and Seta, Y. (2013). Delivery of siRNA to the brain using a combination of nose-to-brain delivery and cell-penetrating peptide-modified nano-micelles. Biomaterials 34, 9220-9226. doi: 10.1016/j.biomaterials.2013.08.036
90. Kanazawa, T., Sugawara, K., Tanaka, K., Horiuchi, S., Takashima, Y., and Okada, H. (2012). Suppression of tumor growth by systemic delivery of anti-VEGF siRNA with cell-penetrating peptide-modified MPEG-PCL nanomicelles. Eur. J. Pharm. Biopharm. 81, 470-477. doi: 10.1016/j.ejpb.2012.04.021
91. Kang, H., Lee, E., Na, K., and Bae, Y. (2008). "Stimuli-sensitive nanosystems: for drug and gene delivery," in Multifunctional Pharmaceutical Nanocarriers, ed V. Torchilin (New York, NY: Springer), 161-199.
92. Kato, K., Chin, K., Yoshikawa, T., Yamaguchi, K., Tsuji, Y., Esaki, T., et al. (2012). Phase II study of NK105, a paclitaxel-incorporating micellar nanoparticle, for previously treated advanced or recurrent gastric cancer. Invest. New Drugs 30, 1621-1627. doi: 10.1007/s10637-011-9709-2
93. Kim, D. H., Vitol, E. A., Liu, J., Balasubramanian, S., Gosztola, D. J., Cohen, E. E., et al. (2013). Stimuli-responsive magnetic nanomicelles as multifunctional heat and cargo delivery vehicles. Langmuir 29, 7425-7432. doi: 10.1021/la3044158
94. Kim, S. H., Jeong, J. H., Lee, S. H., Kim, S. W., and Park, T. G. (2008). Local and systemic delivery of VEGF siRNA using polyelectrolyte complex micelles for effective treatment of cancer. J. Control. Release 129, 107-116. doi: 10.1016/j.jconrel.2008.03.008
95. Kim, T. Y., Kim, D. W., Chung, J. Y., Shin, S. G., Kim, S. C., Heo, D. S., et al. (2004). Phase I and pharmacokinetic study of Genexol-PM, a cremophor-free, polymeric micelle-formulated paclitaxel, in patients with advanced malignancies. Clin. Cancer Res. 10, 3708-3716. doi: 10.1158/1078-0432.CCR-03-0655
96. Kirpotin, D. B., Drummond, D. C., Shao, Y., Shalaby, M. R., Hong, K., Nielsen, U. B., et al. (2006). Antibody targeting of long-circulating lipidic nanoparticles does not increase tumor localization but does increase internalization in animal models. Cancer Res. 66, 6732-6740. doi: 10.1158/0008-5472.CAN-05-4199
97. Koizumi, F., Kitagawa, M., Negishi, T., Onda, T., Matsumoto, S., Hamaguchi, T., et al. (2006). Novel SN-38-incorporating polymeric micelles, NK012, eradicate vascular endothelial growth factor-secreting bulky tumors. Cancer Res. 66, 10048-10056. doi: 10.1158/0008-5472.CAN-06-1605
98. Koo, A. N., Min, K. H., Lee, H. J., Lee, S. U., Kim, K., Kwon, I. C., et al. (2012). Tumor accumulation and antitumor efficacy of docetaxel-loaded core-shell-corona micelles with shell-specific redox-responsive cross-links. Biomaterials 33, 1489-1499. doi: 10.1016/j.biomaterials.2011.11.013
99. Koyamatsu, Y., Hirano, T., Kakizawa, Y., Okano, F., Takarada, T., and Maeda, M. (2013). pH-responsive release of proteins from biocompatible and biodegradable reverse polymer micelles. J. Control. Release 173C, 89-95. doi: 10.1016/j.jconrel.2013.10.035
100. Kumar, S., Allard, J.-F., Morris, D., Dory, Y. L., Lepage, M., and Zhao, Y. (2012). Near-infrared light sensitive polypeptide block copolymer micelles for drug delivery. J. Mater. Chem. 22, 7252-7257. doi: 10.1039/c2jm16380b
101. Laouini, A., Koutroumanis, K. P., Charcosset, C., Georgiadou, S., Fessi, H., Holdich, R. G., et al. (2013). pH-sensitive micelles for targeted drug delivery prepared using a novel membrane contactor method. ACS Appl. Mater. Interfaces 5, 8939-8947. doi: 10.1021/am4018237
102. Leamon, C. P., and Low, P. S. (1991). Delivery of macromolecules into living cells: a method that exploits folate receptor endocytosis. Proc. Natl. Acad. Sci. U.S.A. 88, 5572-5576. doi: 10.1073/pnas.88.13.5572
103. Lee, A. L., Wang, Y., Pervaiz, S., Fan, W., and Yang, Y. Y. (2011a). Synergistic anticancer effects achieved by co-delivery of TRAIL and paclitaxel using cationic polymeric micelles. Macromol. Biosci. 11, 296-307. doi: 10.1002/mabi.201000332
104. Lee, I., Park, M., Kim, Y., Hwang, O., Khang, G., and Lee, D. (2013). Ketal containing amphiphilic block copolymer micelles as pH-sensitive drug carriers. Int. J. Pharm. 448, 259-266. doi: 10.1016/j.ijpharm.2013.03.017
105. Lee, S. H., Mok, H., Lee, Y., and Park, T. G. (2011b). Self-assembled siRNA-PLGA conjugate micelles for gene silencing. J. Control. Release 152, 152-158. doi: 10.1016/j.jconrel.2010.12.007
106. Lewis, C. E., and Pollard, J. W. (2006). Distinct role of macrophages in different tumor microenvironments. Cancer Res. 66, 605-612. doi: 10.1158/0008-5472.CAN-05-4005
107. Li, G., Meng, Y., Guo, L., Zhang, T., and Liu, J. (2013a). Formation of thermo-sensitive polyelectrolyte complex micelles from two biocompatible graft copolymers for drug delivery. J. Biomed. Mater. Res. A. doi: 10.1002/jbm.a.34894. [Epub ahead of print].
108. Li, J., Cheng, D., Yin, T., Chen, W., Lin, Y., Chen, J., et al. (2014). Copolymer of poly(ethylene glycol) and poly(l-lysine) grafting polyethylenimine through a reducible disulfide linkage for siRNA delivery. Nanoscale 6, 1732-1740. doi: 10.1039/c3nr05024f
109. Li, J., Ge, Z., and Liu, S. (2013b). PEG-sheddable polyplex micelles as smart gene carriers based on MMP-cleavable peptide-linked block copolymers. Chem. Commun. (Camb.) 49, 6974-6976. doi: 10.1039/c3cc43576h
110. Li, J., Huo, M., Wang, J., Zhou, J., Mohammad, J. M., Zhang, Y., et al. (2012a). Redox-sensitive micelles self-assembled from amphiphilic hyaluronic acid-deoxycholic acid conjugates for targeted intracellular delivery of paclitaxel. Biomaterials 33, 2310-2320. doi: 10.1016/j.biomaterials.2011.11.022
111. Li, W., Zhao, H., Qian, W., Li, H., Zhang, L., Ye, Z., et al. (2012b). Chemotherapy for gastric cancer by finely tailoring anti-Her2 anchored dual targeting immunomicelles. Biomaterials 33, 5349-5362. doi: 10.1016/j.biomaterials.2012.04.016
112. Li, X., Li, H., Yi, W., Chen, J., and Liang, B. (2013c). Acid-triggered core cross-linked nanomicelles for targeted drug delivery and magnetic resonance imaging in liver cancer cells. Int. J. Nanomedicine 8, 3019-3031. doi: 10.2147/IJN.S45767
113. Li, Y., Gao, G. H., and Lee, D. S. (2013d). Stimulus-sensitive polymeric nanoparticles and their applications as drug and gene carriers. Adv. Healthc. Mater. 2, 388-417. doi: 10.1002/adhm.201200313
114. Li, Y., Liu, T., Zhang, G., Ge, Z., and Liu, S. (2013e). Tumor-targeted redox-responsive nonviral gene delivery nanocarriers based on neutral-cationic brush block copolymers. Macromol. Rapid Commun. 35, 466-473. doi: 10.1002/marc.201300719
115. Li, Y., Ma, J., Zhu, H., Gao, X., Dong, H., and Shi, D. (2013f). Green synthetic, multifunctional hybrid micelles with shell embedded magnetic nanoparticles for theranostic applications. ACS Appl. Mater. Interfaces 5, 7227-7235. doi: 10.1021/am401573b
116. Li, Y., Qian, Y., Liu, T., Zhang, G., and Liu, S. (2012c). Light-triggered concomitant enhancement of magnetic resonance imaging contrast performance and drug release rate of functionalized amphiphilic diblock copolymer micelles. Biomacromolecules 13, 3877-3886. doi: 10.1021/bm301425j
117. Li, Y., Xiao, K., Luo, J., Xiao, W., Lee, J. S., Gonik, A. M., et al. (2011). Well-defined, reversible disulfide cross-linked micelles for on-demand paclitaxel delivery. Biomaterials 32, 6633-6645. doi: 10.1016/j.biomaterials.2011.05.050
118. Li, Y., Yang, F., Chen, W., Liu, J., Huang, W., Jin, M., et al. (2012d). A novel monomethoxy polyethylene glycol-polylactic acid polymeric micelles with higher loading capacity for docetaxel and well-reconstitution characteristics and its anti-metastasis study. Chem. Pharm. Bull. (Tokyo) 60, 1146-1154. doi: 10.1248/cpb.c12-00323
119. Liao, C., Sun, Q., Liang, B., Shen, J., and Shuai, X. (2011). Targeting EGFR-overexpressing tumor cells using Cetuximab-immunomicelles loaded with doxorubicin and superparamagnetic iron oxide. Eur. J. Radiol. 80, 699-705. doi: 10.1016/j.ejrad.2010.08.005
120. Lin, G. Y., Lv, H. F., Lu, C. T., Chen, L. J., Lin, M., Zhang, M., et al. (2013). Construction and application of biotin-poloxamer conjugate micelles for chemotherapeutics. J. Microencapsul. 30, 538-545. doi: 10.3109/02652048.2012.758182
121. Liu, G.-Y., Chen, C.-J., Li, D.-D., Wang, S.-S., and Ji, J. (2012). Near-infrared light-sensitive micelles for enhanced intracellular drug delivery. J. Mater. Chem. 22, 16865-16871. doi: 10.1039/c2jm00045h
122. Liu, X.-Q., Sun, C.-Y., Yang, X.-Z., and Wang, J. (2013). Polymeric-Micelle-Based Nanomedicine for siRNA Delivery. Part. Part. Syst. Charact. 30, 211-228. doi: 10.1002/ppsc.201200061
123. Liu, Z., and Zhang, N. (2012). pH-Sensitive polymeric micelles for programmable drug and gene delivery. Curr. Pharm. Des. 18, 3442-3451. doi: 10.2174/138161212801227122
124. Lu, Y., and Park, K. (2013). Polymeric micelles and alternative nanonized delivery vehicles for poorly soluble drugs. Int. J. Pharm. 453, 198-214. doi: 10.1016/j.ijpharm.2012.08.042
125. Macdiarmid, J. A., Amaro-Mugridge, N. B., Madrid-Weiss, J., Sedliarou, I., Wetzel, S., Kochar, K., et al. (2009). Sequential treatment of drug-resistant tumors with targeted minicells containing siRNA or a cytotoxic drug. Nat. Biotechnol. 27, 643-651. doi: 10.1038/nbt.1547
126. Maeda, H., Wu, J., Sawa, T., Matsumura, Y., and Hori, K. (2000). Tumor vascular permeability and the EPR effect in macromolecular therapeutics: a review. J. Control. Release 65, 271-284. doi: 10.1016/S0168-3659(99)00248-5
127. Mahmud, A., Xiong, X. B., Aliabadi, H. M., and Lavasanifar, A. (2007). Polymeric micelles for drug targeting. J. Drug Target. 15, 553-584. doi: 10.1080/10611860701538586
128. Martinez, J., Patkaniowska, A., Urlaub, H., Luhrmann, R., and Tuschl, T. (2002). Single-stranded antisense siRNAs guide target RNA cleavage in RNAi. Cell 110, 563-574. doi: 10.1016/S0092-8674(02)00908-X
129. Matsumoto, S., Christie, R. J., Nishiyama, N., Miyata, K., Ishii, A., Oba, M., et al. (2008). Environment-responsive block copolymer micelles with a disulfide cross-linked core for enhanced siRNA delivery. Biomacromolecules 10, 119-127. doi: 10.1021/bm800985e
130. Matsumoto, S., Christie, R. J., Nishiyama, N., Miyata, K., Ishii, A., Oba, M., et al. (2009). Environment-responsive block copolymer micelles with a disulfide cross-linked core for enhanced siRNA delivery. Biomacromolecules 10, 119-127. doi: 10.1021/bm800985e
131. Matsumura, Y., Hamaguchi, T., Ura, T., Muro, K., Yamada, Y., Shimada, Y., et al. (2004). Phase I clinical trial and pharmacokinetic evaluation of NK911, a micelle-encapsulated doxorubicin. Br. J. Cancer 91, 1775-1781. doi: 10.1038/sj.bjc.6602204
132. Matsumura, Y., and Maeda, H. (1986). A new concept for macromolecular therapeutics in cancer chemotherapy: mechanism of tumoritropic accumulation of proteins and the antitumor agent smancs. Cancer Res. 46, 6387-6392.
133. Meister, G., and Tuschl, T. (2004). Mechanisms of gene silencing by double-stranded RNA. Nature 431, 343-349. doi: 10.1038/nature02873
134. Menon, S., Thekkayil, R., Varghese, S., and Das, S. (2011). Photoresponsive soft materials: synthesis and photophysical studies of a stilbene-based diblock copolymer. J. Polym. Sci. A Polym. Chem. 49, 5063-5073. doi: 10.1002/pola.24973
135. Min, K. H., Kim, J. H., Bae, S. M., Shin, H., Kim, M. S., Park, S., et al. (2010). Tumoral acidic pH-responsive MPEG-poly(beta-amino ester) polymeric micelles for cancer targeting therapy. J. Control. Release 144, 259-266. doi: 10.1016/j.jconrel.2010.02.024
136. Miura, Y., Takenaka, T., Toh, K., Wu, S., Nishihara, H., Kano, M. R., et al. (2013). Cyclic RGD-linked polymeric micelles for targeted delivery of platinum anticancer drugs to glioblastoma through the blood-brain tumor barrier. ACS nano 7, 8583-8592. doi: 10.1021/nn402662d
137. Mohan, P., and Rapoport, N. (2010). Doxorubicin as a molecular nanotheranostic agent: effect of doxorubicin encapsulation in micelles or nanoemulsions on the ultrasound-mediated intracellular delivery and nuclear trafficking. Mol. Pharm. 7, 1959-1973. doi: 10.1021/mp100269f
138. Monsky, W. L., Fukumura, D., Gohongi, T., Ancukiewcz, M., Weich, H. A., Torchilin, V. P., et al. (1999). Augmentation of transvascular transport of macromolecules and nanoparticles in tumors using vascular endothelial growth factor. Cancer Res. 59, 4129-4135.
139. Mori, T. (2004). Cancer-specific ligands identified from screening of peptide-display libraries. Curr. Pharm. Des. 10, 2335-2343. doi: 10.2174/1381612043383944
140. Mura, S., Nicolas, J., and Couvreur, P. (2013). Stimuli-responsive nanocarriers for drug delivery. Nat. Mater. 12, 991-1003. doi: 10.1038/nmat3776
141. Musacchio, T., and Torchilin, V. P. (2013). siRNA delivery: from basics to therapeutic applications. Front. Biosci. (Landmark Ed) 18, 58-79. doi: 10.2741/4087
142. Musacchio, T., Vaze, O., D'Souza, G., and Torchilin, V. P. (2010). Effective stabilization and delivery of siRNA: reversible siRNA-phospholipid conjugate in nanosized mixed polymeric micelles. Bioconjug. Chem. 21, 1530-1536. doi: 10.1021/bc100199c
143. Navarro, G., Essex, S., and Torchilin, V. (2013). "The 'Non-viral' approach for siRNA delivery in cancer treatment: a special focus on micelles and liposomes," in DNA and RNA Nanobiotechnologies in Medicine: Diagnosis and Treatment of Diseases, eds V. A. Erdmann and J. Barciszewski (Berlin; Heidelberg: Springer), 241-261. doi: 10.1007/978-3-642-36853-0_10
144. Nie, S., Xing, Y., Kim, G. J., and Simons, J. W. (2007). Nanotechnology applications in cancer. Annu. Rev. Biomed. Eng. 9, 257-288. doi: 10.1146/annurev.bioeng.9.060906.152025
145. Oerlemans, C., Bult, W., Bos, M., Storm, G., Nijsen, J. F., and Hennink, W. E. (2010). Polymeric micelles in anticancer therapy: targeting, imaging and triggered release. Pharm. Res. 27, 2569-2589. doi: 10.1007/s11095-010-0233-4
146. Oishi, M., Nagasaki, Y., Itaka, K., Nishiyama, N., and Kataoka, K. (2005). Lactosylated poly(ethylene glycol)-siRNA conjugate through acid-labile beta-thiopropionate linkage to construct pH-sensitive polyion complex micelles achieving enhanced gene silencing in hepatoma cells. J. Am. Chem. Soc. 127, 1624-1625. doi: 10.1021/ja044941d
147. Padera, T. P., Stoll, B. R., Tooredman, J. B., Capen, D., Di Tomaso, E., and Jain, R. K. (2004). Pathology: cancer cells compress intratumour vessels. Nature 427, 695. doi: 10.1038/427695a
148. Palanca-Wessels, M. C., Convertine, A. J., Cutler-Strom, R., Booth, G. C., Lee, F., Berguig, G. Y., et al. (2011). Anti-CD22 antibody targeting of pH-responsive micelles enhances small interfering RNA delivery and gene silencing in lymphoma cells. Mol. Ther. 19, 1529-1537. doi: 10.1038/mt.2011.104
149. Park, J. H., Lee, S., Kim, J.-H., Park, K., Kim, K., and Kwon, I. C. (2008). Polymeric nanomedicine for cancer therapy. Prog. Polym. Sci. 33, 113-137. doi: 10.1016/j.progpolymsci.2007.09.003
150. Pecot, C. V., Calin, G. A., Coleman, R. L., Lopez-Berestein, G., and Sood, A. K. (2011). RNA interference in the clinic: challenges and future directions. Nat. Rev. Cancer 11, 59-67. doi: 10.1038/nrc2966
151. Peer, D., Karp, J. M., Hong, S., Farokhzad, O. C., Margalit, R., and Langer, R. (2007). Nanocarriers as an emerging platform for cancer therapy. Nat. Nanotechnol. 2, 751-760. doi: 10.1038/nnano.2007.387
152. Perche, F., Biswas, S., Wang, T., Zhu, L., and Torchilin, V. P. (2014). Hypoxia-targeted siRNA delivery. Angew. Chem. Int. Ed. Engl. 53, 3362-3366. doi: 10.1002/ange.201308368
153. Perche, F., Patel, N. R., and Torchilin, V. P. (2012). Accumulation and toxicity of antibody-targeted doxorubicin-loaded PEG-PE micelles in ovarian cancer cell spheroid model. J. Control. Release 164, 95-102. doi: 10.1016/j.jconrel.2012.09.003
154. Petrenko, V. (2008). Evolution of phage display: from bioactive peptides to bioselective nanomaterials. Expert Opin. Drug Deliv. 5, 825-836. doi: 10.1517/17425247.5.8.825
155. Petros, R. A., and Desimone, J. M. (2010). Strategies in the design of nanoparticles for therapeutic applications. Nat. Rev. Drug Discov. 9, 615-627. doi: 10.1038/nrd2591
156. Plummer, R., Wilson, R. H., Calvert, H., Boddy, A. V., Griffin, M., Sludden, J., et al. (2011). A Phase I clinical study of cisplatin-incorporated polymeric micelles (NC-6004) in patients with solid tumours. Br. J. Cancer 104, 593-598. doi: 10.1038/bjc.2011.6
157. Prabaharan, M., Grailer, J. J., Steeber, D. A., and Gong, S. (2009). Thermosensitive micelles based on folate-conjugated poly(N-vinylcaprolactam)-block-poly(ethylene glycol) for tumor-targeted drug delivery. Macromol. Biosci. 9, 744-753. doi: 10.1002/mabi.200800366
158. Prabhakar, U., Maeda, H., Jain, R. K., Sevick-Muraca, E. M., Zamboni, W., Farokhzad, O. C., et al. (2013). Challenges and key considerations of the enhanced permeability and retention effect for nanomedicine drug delivery in oncology. Cancer Res. 73, 2412-2417. doi: 10.1158/0008-5472.CAN-12-4561
159. Qian, Y., Zha, Y., Feng, B., Pang, Z., Zhang, B., Sun, X., et al. (2013). PEGylated poly(2-(dimethylamino) ethyl methacrylate)/DNA polyplex micelles decorated with phage-displayed TGN peptide for brain-targeted gene delivery. Biomaterials 34, 2117-2129. doi: 10.1016/j.biomaterials.2012.11.050
160. Qiu, L. Y., Yan, L., Zhang, L., Jin, Y. M., and Zhao, Q. H. (2013). Folate-modified poly(2-ethyl-2-oxazoline) as hydrophilic corona in polymeric micelles for enhanced intracellular doxorubicin delivery. Int. J. Pharm. 456, 315-324. doi: 10.1016/j.ijpharm.2013.08.071
161. Rana, T. M. (2007). Illuminating the silence: understanding the structure and function of small RNAs. Nat. Rev. Mol. Cell Biol. 8, 23-36. doi: 10.1038/nrm2085
162. Rapoport, N. (2012). Ultrasound-mediated micellar drug delivery. Int. J. Hyperthermia 28, 374-385. doi: 10.3109/02656736.2012.665567
163. Rapoport, N., Kennedy, A. M., Shea, J. E., Scaife, C. L., and Nam, K. H. (2010). Ultrasonic nanotherapy of pancreatic cancer: lessons from ultrasound imaging. Mol. Pharm. 7, 22-31. doi: 10.1021/mp900128x
164. Riehle, R. D., Cornea, S., Degterev, A., and Torchilin, V. (2013). Micellar formulations of pro-apoptotic DM-PIT-1 analogs and TRAIL in vitro and in vivo. Drug. Deliv. 20, 78-85. doi: 10.3109/10717544.2013.766780
165. Roberts, W. G., and Palade, G. E. (1997). Neovasculature induced by vascular endothelial growth factor is fenestrated. Cancer Res. 57, 765-772.
166. Saito, G., Swanson, J. A., and Lee, K. D. (2003). Drug delivery strategy utilizing conjugation via reversible disulfide linkages: role and site of cellular reducing activities. Adv. Drug Deliv. Rev. 55, 199-215. doi: 10.1016/S0169-409X(02)00179-5
167. Salzano, G., Riehle, R., Navarro, G., Perche, F., De Rosa, G., and Torchilin, V. P. (2014). Polymeric micelles containing reversibly phospholipid-modified anti-survivin siRNA: a promising strategy to overcome drug resistance in cancer. Cancer Lett. 343, 224-231. doi: 10.1016/j.canlet.2013.09.037
168. Sarisozen, C., Vural, I., Levchenko, T., Hincal, A. A., and Torchilin, V. P. (2012). Long-circulating PEG-PE micelles co-loaded with paclitaxel and elacridar (GG918) overcome multidrug resistance. Drug. Deliv. 19, 363-370. doi: 10.3109/10717544.2012.724473
169. Sashital, D. G., and Doudna, J. A. (2010). Structural insights into RNA interference. Curr. Opin. Struct. Biol. 20, 90-97. doi: 10.1016/j.sbi.2009.12.001
170. Sawant, R. R., Jhaveri, A. M., Koshkaryev, A., Qureshi, F., and Torchilin, V. P. (2013a). The effect of dual ligand-targeted micelles on the delivery and efficacy of poorly soluble drug for cancer therapy. J. Drug Target. 21, 630-638. doi: 10.3109/1061186X.2013.789032
171. Sawant, R. R., Jhaveri, A. M., Koshkaryev, A., Zhu, L., Qureshi, F., and Torchilin, V. P. (2013b). Targeted transferrin-modified polymeric micelles: enhanced efficacy in vitro and in vivo in ovarian carcinoma. Mol. Pharm. 11, 375-381. doi: 10.1021/mp300633f
172. Sawant, R. R., Jhaveri, A. M., and Torchilin, V. P. (2012). Immunomicelles for advancing personalized therapy. Adv. Drug Deliv. Rev. 64, 1436-1446. doi: 10.1016/j.addr.2012.08.003
173. Sawant, R. R., and Torchilin, V. P. (2010). Multifunctionality of lipid-core micelles for drug delivery and tumour targeting. Mol. Membr. Biol. 27, 232-246. doi: 10.3109/09687688.2010.516276
174. Schroeder, A., Heller, D. A., Winslow, M. M., Dahlman, J. E., Pratt, G. W., Langer, R., et al. (2012). Treating metastatic cancer with nanotechnology. Nat. Rev. Cancer 12, 39-50. doi: 10.1038/nrc3180
175. Schumers, J. M., Fustin, C. A., and Gohy, J. F. (2010). Light-responsive block copolymers. Macromol. Rapid Commun. 31, 1588-1607. doi: 10.1002/marc.201000108
176. Sharma, A. K., Zhang, L., Li, S., Kelly, D. L., Alakhov, V. Y., Batrakova, E. V., et al. (2008). Prevention of MDR development in leukemia cells by micelle-forming polymeric surfactant. J. Control. Release 131, 220-227. doi: 10.1016/j.jconrel.2008.07.031
177. Shen, H., Sun, T., and Ferrari, M. (2012). Nanovector delivery of siRNA for cancer therapy. Cancer Gene Ther. 19, 367-373. doi: 10.1038/cgt.2012.22
178. Shukla, S., Wu, C. P., and Ambudkar, S. V. (2008). Development of inhibitors of ATP-binding cassette drug transporters: present status and challenges. Expert Opin. Drug Metab. Toxicol. 4, 205-223. doi: 10.1517/17425255.4.2.205
179. Singh, M. (1999). Transferrin As A targeting ligand for liposomes and anticancer drugs. Curr. Pharm. Des. 5, 443-451.
180. Singh, S., Narang, A. S., and Mahato, R. I. (2011). Subcellular fate and off-target effects of siRNA, shRNA, and miRNA. Pharm. Res. 28, 2996-3015. doi: 10.1007/s11095-011-0608-1
181. Skidan, I., Miao, B., Thekkedath, R. V., Dholakia, P., Degterev, A., and Torchilin, V. (2009). In vitro cytotoxicity of novel pro-apoptotic agent DM-PIT-1 in PEG-PE-based micelles alone and in combination with TRAIL. Drug. Deliv. 16, 45-51. doi: 10.1080/10717540802517951
182. Son, S., Shin, E., and Kim, B. S. (2014). Light-responsive micelles of spiropyran initiated hyperbranched polyglycerol for smart drug delivery. Biomacromolecules 15, 628-634. doi: 10.1021/bm401670t
183. Song, N., Ding, M., Pan, Z., Li, J., Zhou, L., Tan, H., et al. (2013). Construction of targeting-clickable and tumor-cleavable polyurethane nanomicelles for multifunctional intracellular drug delivery. Biomacromolecules 14, 4407-4419. doi: 10.1021/bm401342t
184. Song, W., Tang, Z., Zhang, D., Zhang, Y., Yu, H., Li, M., et al. (2014). Anti-tumor efficacy of c(RGDfK)-decorated polypeptide-based micelles co-loaded with docetaxel and cisplatin. Biomaterials 35, 3005-3014. doi: 10.1016/j.biomaterials.2013.12.018
185. Spankuch, B., Kurunci-Csacsko, E., Kaufmann, M., and Strebhardt, K. (2007). Rational combinations of siRNAs targeting Plk1 with breast cancer drugs. Oncogene 26, 5793-5807. doi: 10.1038/sj.onc.1210355
186. Su, C. W., Chen, S. Y., and Liu, D. M. (2013). Polysaccharide-lecithin reverse micelles with enzyme-degradable triglyceride shell for overcoming tumor multidrug resistance. Chem. Commun. (Camb.) 49, 3772-3774. doi: 10.1039/c3cc40836a
187. Sudimack, J., and Lee, R. J. (2000). Targeted drug delivery via the folate receptor. Adv. Drug Deliv. Rev. 41, 147-162. doi: 10.1016/S0169-409X(99)00062-9
188. Suma, T., Miyata, K., Ishii, T., Uchida, S., Uchida, H., Itaka, K., et al. (2012). Enhanced stability and gene silencing ability of siRNA-loaded polyion complexes formulated from polyaspartamide derivatives with a repetitive array of amino groups in the side chain. Biomaterials 33, 2770-2779. doi: 10.1016/j.biomaterials.2011.12.022
189. Sun, L., Yang, Y., Dong, C. M., and Wei, Y. (2011a). Two-photon-sensitive and sugar-targeted nanocarriers from degradable and dendritic amphiphiles. Small 7, 401-406. doi: 10.1002/smll.201001729
190. Sun, T. M., Du, J. Z., Yao, Y. D., Mao, C. Q., Dou, S., Huang, S. Y., et al. (2011b). Simultaneous delivery of siRNA and paclitaxel via a "two-in-one" micelleplex promotes synergistic tumor suppression. ACS Nano 5, 1483-1494. doi: 10.1021/nn103349h
191. Sutton, D., Nasongkla, N., Blanco, E., and Gao, J. (2007). Functionalized micellar systems for cancer targeted drug delivery. Pharm. Res. 24, 1029-1046. doi: 10.1007/s11095-006-9223-y
192. Taki, H., Kanazawa, T., Akiyama, F., Takashima, Y., and Okada, H. (2012). Intranasal delivery of camptothecin-loaded tat-modified nanomicells for treatment of intracranial brain tumors. Pharmaceuticals (Basel) 5, 1092-1102. doi: 10.3390/ph5101092
193. Tanaka, K., Kanazawa, T., Horiuchi, S., Ando, T., Sugawara, K., Takashima, Y., et al. (2013). Cytoplasm-responsive nanocarriers conjugated with a functional cell-penetrating peptide for systemic siRNA delivery. Int. J. Pharm. 455, 40-47. doi: 10.1016/j.ijpharm.2013.07.069
194. Tannock, I. F., and Rotin, D. (1989). Acid pH in tumors and its potential for therapeutic exploitation. Cancer Res. 49, 4373-4384.
195. Taylor, R. M., and Sillerud, L. O. (2012). Paclitaxel-loaded iron platinum stealth immunomicelles are potent MRI imaging agents that prevent prostate cancer growth in a PSMA-dependent manner. Int. J. Nanomedicine 7, 4341-4352. doi: 10.2147/IJN.S34381
196. Tong, S. W., Xiang, B., Dong, D. W., and Qi, X. R. (2012). Enhanced antitumor efficacy and decreased toxicity by self-associated docetaxel in phospholipid-based micelles. Int. J. Pharm. 434, 413-419. doi: 10.1016/j.ijpharm.2012.06.014
197. Torchilin, V. (2009). Multifunctional and stimuli-sensitive pharmaceutical nanocarriers. Eur. J. Pharm. Biopharm. 71, 431-444. doi: 10.1016/j.ejpb.2008.09.026
198. Torchilin, V. (2011). Tumor delivery of macromolecular drugs based on the EPR effect. Adv. Drug Deliv. Rev. 63, 131-135. doi: 10.1016/j.addr.2010.03.011
199. Torchilin, V. P. (2001). Structure and design of polymeric surfactant-based drug delivery systems. J. Control. Release 73, 137-172. doi: 10.1016/S0168-3659(01)00299-1
200. Torchilin, V. P. (2002). PEG-based micelles as carriers of contrast agents for different imaging modalities. Adv. Drug Deliv. Rev. 54, 235-252. doi: 10.1016/S0169-409X(02)00019-4
201. Torchilin, V. P. (2004). Targeted polymeric micelles for delivery of poorly soluble drugs. Cell. Mol. Life Sci. 61, 2549-2559. doi: 10.1007/s00018-004-4153-5
202. Torchilin, V. P. (2006). Multifunctional nanocarriers. Adv. Drug Deliv. Rev. 58, 1532-1555. doi: 10.1016/j.addr.2006.09.009
203. Torchilin, V. P. (2007). Micellar nanocarriers: pharmaceutical perspectives. Pharm. Res. 24, 1-16. doi: 10.1007/s11095-006-9132-0
204. Torchilin, V. P., Lukyanov, A. N., Gao, Z., and Papahadjopoulos-Sternberg, B. (2003). Immunomicelles: targeted pharmaceutical carriers for poorly soluble drugs. Proc. Natl. Acad. Sci. U.S.A. 100, 6039-6044. doi: 10.1073/pnas.0931428100
205. Torchilin, V. P., and Trubetskoy, V. S. (1995). Which polymers can make nanoparticulate drug carriers long-circulating? Adv. Drug Deliv. Rev. 16, 141-155. doi: 10.1016/0169-409X(95)00022-Y
206. Valle, J. W., Armstrong, A., Newman, C., Alakhov, V., Pietrzynski, G., Brewer, J., et al. (2011). A phase 2 study of SP1049C, doxorubicin in P-glycoprotein-targeting pluronics, in patients with advanced adenocarcinoma of the esophagus and gastroesophageal junction. Invest. New Drugs 29, 1029-1037. doi: 10.1007/s10637-010-9399-1
207. Varshosaz, J., Sadeghi-Aliabadi, H., Ghasemi, S., and Behdadfar, B. (2013). Use of magnetic folate-dextran-retinoic acid micelles for dual targeting of doxorubicin in breast cancer. Biomed Res. Int. 2013:680712. doi: 10.1155/2013/680712
208. Wan, C. P., Jackson, J. K., Pirmoradi, F. N., Chiao, M., and Burt, H. M. (2012). Increased accumulation and retention of micellar paclitaxel in drug-sensitive and P-glycoprotein-expressing cell lines following ultrasound exposure. Ultrasound Med. Biol. 38, 736-744. doi: 10.1016/j.ultrasmedbio.2012.01.023
209. Wang, A. Z., Langer, R., and Farokhzad, O. C. (2012a). Nanoparticle delivery of cancer drugs. Annu. Rev. Med. 63, 185-198. doi: 10.1146/annurev-med-040210-162544
210. Wang, C., Chen, Q., Wang, Z., and Zhang, X. (2010a). An enzyme-responsive polymeric superamphiphile. Angew. Chem. Int. Ed. Engl. 49, 8612-8615. doi: 10.1002/anie.201004253
211. Wang, C., Ravi, S., Martinez, G. V., Chinnasamy, V., Raulji, P., Howell, M., et al. (2012b). Dual-purpose magnetic micelles for MRI and gene delivery. J. Control. Release 163, 82-92. doi: 10.1016/j.jconrel.2012.04.030
212. Wang, H.-X., Xiong, M.-H., Wang, Y.-C., Zhu, J., and Wang, J. (2013). N-acetylgalactosamine functionalized mixed micellar nanoparticles for targeted delivery of siRNA to liver. J. Control. Release 166, 106-114. doi: 10.1016/j.jconrel.2012.12.017
213. Wang, J., Lu, Z., Wientjes, M. G., and Au, J. L. (2010b). Delivery of siRNA therapeutics: barriers and carriers. AAPS J. 12, 492-503. doi: 10.1208/s12248-010-9210-4
214. Wang, T., Petrenko, V. A., and Torchilin, V. P. (2010c). Paclitaxel-loaded polymeric micelles modified with MCF-7 cell-specific phage protein: enhanced binding to target cancer cells and increased cytotoxicity. Mol. Pharm. 7, 1007-1014. doi: 10.1021/mp1001125
215. Wang, X., Li, S., Wan, Z., Quan, Z., and Tan, Q. (2014). Investigation of thermo-sensitive amphiphilic micelles as drug carriers for chemotherapy in cholangiocarcinoma in vitro and in vivo. Int. J. Pharm. 463, 81-88. doi: 10.1016/j.ijpharm.2013.12.046
216. Wang, Z., Yu, Y., Ma, J., Zhang, H., Wang, X., Wang, J., et al. (2012c). LyP-1 modification to enhance delivery of artemisinin or fluorescent probe loaded polymeric micelles to highly metastatic tumor and its lymphatics. Mol. Pharm. 9, 2646-2657. doi: 10.1021/mp3002107
217. Watts, J. K., Deleavey, G. F., and Damha, M. J. (2008). Chemically modified siRNA: tools and applications. Drug Discov. Today 13, 842-855. doi: 10.1016/j.drudis.2008.05.007
218. Wei, H., Zhuo, R.-X., and Zhang, X.-Z. (2012a). Design and development of polymeric micelles with cleavable links for intracellular drug delivery. Prog. Polym. Sci. 38, 503-535. doi: 10.1016/j.progpolymsci.2012.07.002
219. Wei, X., Wang, Y., Zeng, W., Huang, F., Qin, L., Zhang, C., et al. (2012b). Stability influences the biodistribution, toxicity, and anti-tumor activity of doxorubicin encapsulated in PEG-PE micelles in mice. Pharm. Res. 29, 1977-1989. doi: 10.1007/s11095-012-0725-5
220. Weiner, L. M. (2007). Building better magic bullets-improving unconjugated monoclonal antibody therapy for cancer. Nat. Rev. Cancer 7, 701-706. doi: 10.1038/nrc2209
221. Whitehead, K. A., Langer, R., and Anderson, D. G. (2009). Knocking down barriers: advances in siRNA delivery. Nat. Rev. Drug Discov. 8, 129-138. doi: 10.1038/nrd2742
222. Williams, H. D., Trevaskis, N. L., Charman, S. A., Shanker, R. M., Charman, W. N., Pouton, C. W., et al. (2013). Strategies to address low drug solubility in discovery and development. Pharmacol. Rev. 65, 315-499. doi: 10.1124/pr.112.005660
223. Wu, H., Hait, W. N., and Yang, J. M. (2003). Small interfering RNA-induced suppression of MDR1 (P-glycoprotein) restores sensitivity to multidrug-resistant cancer cells. Cancer Res. 63, 1515-1519.
224. Wu, H., Zhu, L., and Torchilin, V. P. (2013). pH-sensitive poly(histidine)-PEG/DSPE-PEG co-polymer micelles for cytosolic drug delivery. Biomaterials 34, 1213-1222. doi: 10.1016/j.biomaterials.2012.08.072
225. Wu, J., Akaike, T., and Maeda, H. (1998). Modulation of enhanced vascular permeability in tumors by a bradykinin antagonist, a cyclooxygenase inhibitor, and a nitric oxide scavenger. Cancer Res. 58, 159-165.
226. Xing, Y., Wang, C., Han, P., Wang, Z., and Zhang, X. (2012). Acetylcholinesterase responsive polymeric supra-amphiphiles for controlled self-assembly and disassembly. Langmuir 28, 6032-6036. doi: 10.1021/la300612k
227. Xiong, X. B., and Lavasanifar, A. (2011). Traceable multifunctional micellar nanocarriers for cancer-targeted co-delivery of MDR-1 siRNA and doxorubicin. ACS Nano 5, 5202-5213. doi: 10.1021/nn2013707
228. Xiong, X. B., Uludag, H., and Lavasanifar, A. (2010). Virus-mimetic polymeric micelles for targeted siRNA delivery. Biomaterials 31, 5886-5893. doi: 10.1016/j.biomaterials.2010.03.075
229. Xu, W., Burke, J. F., Pilla, S., Chen, H., Jaskula-Sztul, R., and Gong, S. (2013a). Octreotide-functionalized and resveratrol-loaded unimolecular micelles for targeted neuroendocrine cancer therapy. Nanoscale 5, 9924-9933. doi: 10.1039/c3nr03102k
230. Xu, W., Siddiqui, I. A., Nihal, M., Pilla, S., Rosenthal, K., Mukhtar, H., et al. (2013b). Aptamer-conjugated and doxorubicin-loaded unimolecular micelles for targeted therapy of prostate cancer. Biomaterials 34, 5244-5253. doi: 10.1016/j.biomaterials.2013.03.006
231. Yang, C., Zhao, H., Yuan, H., Yu, R., and Lan, M. (2013). Preparation and characterization of thermosensitive and folate functionalized Pluronic micelles. J. Nanosci. Nanotechnol. 13, 6553-6559. doi: 10.1166/jnn.2013.7520
232. Yang, R., Meng, F., Ma, S., Huang, F., Liu, H., and Zhong, Z. (2011). Galactose-decorated cross-linked biodegradable poly(ethylene glycol)-b-poly(epsilon-caprolactone) block copolymer micelles for enhanced hepatoma-targeting delivery of paclitaxel. Biomacromolecules 12, 3047-3055. doi: 10.1021/bm2006856
233. Yang, X. L., Luo, Y. L., Xu, F., and Chen, Y. S. (2014). Thermosensitive mPEG-b-PA-g-PNIPAM comb block copolymer micelles: effect of hydrophilic chain length and camptothecin release behavior. Pharm. Res. 31, 291-304. doi: 10.1007/s11095-013-1160-y
234. Yin, T., Wang, P., Li, J., Zheng, R., Zheng, B., Cheng, D., et al. (2013). Ultrasound-sensitive siRNA-loaded nanobubbles formed by hetero-assembly of polymeric micelles and liposomes and their therapeutic effect in gliomas. Biomaterials 34, 4532-4543. doi: 10.1016/j.biomaterials.2013.02.067
235. Yokoyama, M., Miyauchi, M., Yamada, N., Okano, T., Sakurai, Y., Kataoka, K., et al. (1990). Characterization and anticancer activity of the micelle-forming polymeric anticancer drug adriamycin-conjugated poly(ethylene glycol)-poly(aspartic acid) block copolymer. Cancer Res. 50, 1693-1700.
236. Yokoyama, M., Satoh, A., Sakurai, Y., Okano, T., Matsumura, Y., Kakizoe, T., et al. (1998). Incorporation of water-insoluble anticancer drug into polymeric micelles and control of their particle size. J. Control. Release 55, 219-229. doi: 10.1016/S0168-3659(98)00054-6
237. Yong, D., Luo, Y., Du, F., Huang, J., Lu, W., Dai, Z., et al. (2013). CDDP supramolecular micelles fabricated from adamantine terminated mPEG and beta-cyclodextrin based seven-armed poly (L-glutamic acid)/CDDP complexes. Colloids Surf. B Biointerfaces 105, 31-36. doi: 10.1016/j.colsurfb.2012.12.046
238. Yu, C., Gao, C., Lu, S., Chen, C., Yang, J., Di, X., et al. (2013a). Facile preparation of pH-sensitive micelles self-assembled from amphiphilic chondroitin sulfate-histamine conjugate for triggered intracellular drug release. Colloids Surf. B Biointerfaces 115C, 331-339. doi: 10.1016/j.colsurfb.2013.12.023
239. Yu, H., Zou, Y., Wang, Y., Huang, X., Huang, G., Sumer, B. D., et al. (2011). Overcoming endosomal barrier by amphotericin B-loaded dual pH-responsive PDMA-b-PDPA micelleplexes for siRNA delivery. ACS nano 5, 9246-9255. doi: 10.1021/nn203503h
240. Yu, J. M., Li, W. D., Lu, L., Zhou, X. Y., Wang, D. Y., Li, H. M., et al. (2014). Preparation and characterization of galactosylated glycol chitosan micelles and its potential use for hepatoma-targeting delivery of doxorubicin. J. Mater. Sci. Mater. Med. 25, 691-701. doi: 10.1007/s10856-013-5109-9
241. Yu, S. S., Lau, C. M., Barham, W. J., Onishko, H. M., Nelson, C. E., Li, H., et al. (2013b). Macrophage-specific RNA interference targeting via "click," mannosylated polymeric micelles. Mol. Pharm. 10, 975-987. doi: 10.1021/mp300434e
242. Yuan, F., Chen, Y., Dellian, M., Safabakhsh, N., Ferrara, N., and Jain, R. K. (1996). Time-dependent vascular regression and permeability changes in established human tumor xenografts induced by an anti-vascular endothelial growth factor/vascular permeability factor antibody. Proc. Natl. Acad. Sci. U.S.A. 93, 14765-14770. doi: 10.1073/pnas.93.25.14765
243. Yuan, F., Dellian, M., Fukumura, D., Leunig, M., Berk, D. A., Torchilin, V. P., et al. (1995). Vascular permeability in a human tumor xenograft: molecular size dependence and cutoffsize. Cancer Res. 55, 3752-3756.
244. Zeng, F., Lee, H., and Allen, C. (2006). Epidermal growth factor-conjugated poly(ethylene glycol)-block- poly(delta-valerolactone) copolymer micelles for targeted delivery of chemotherapeutics. Bioconjug. Chem. 17, 399-409. doi: 10.1021/bc050350g
245. Zhang, L., Gong, F., Zhang, F., Ma, J., Zhang, P., and Shen, J. (2013). Targeted therapy for human hepatic carcinoma cells using folate-functionalized polymeric micelles loaded with superparamagnetic iron oxide and sorafenib in vitro. Int. J. Nanomedicine 8, 1517-1524. doi: 10.2147/IJN.S43263
246. Zhang, L., Lu, Z., Zhao, Q., Huang, J., Shen, H., and Zhang, Z. (2011a). Enhanced chemotherapy efficacy by sequential delivery of siRNA and anticancer drugs using PEI-grafted graphene oxide. Small 7, 460-464. doi: 10.1002/smll.201001522
247. Zhang, W., Shi, Y., Chen, Y., Hao, J., Sha, X., and Fang, X. (2011b). The potential of Pluronic polymeric micelles encapsulated with paclitaxel for the treatment of melanoma using subcutaneous and pulmonary metastatic mice models. Biomaterials 32, 5934-5944. doi: 10.1016/j.biomaterials.2011.04.075
248. Zhang, W., Shi, Y., Chen, Y., Yu, S., Hao, J., Luo, J., et al. (2010). Enhanced antitumor efficacy by paclitaxel-loaded pluronic P123/F127 mixed micelles against non-small cell lung cancer based on passive tumor targeting and modulation of drug resistance. Eur. J. Pharm. Biopharm. 75, 341-353. doi: 10.1016/j.ejpb.2010.04.017
249. Zhang, Y., Hong, H., and Cai, W. (2011c). Tumor-targeted drug delivery with aptamers. Curr. Med. Chem. 18, 4185-4194. doi: 10.2174/092986711797189547
250. Zhao, J., Mi, Y., and Feng, S. S. (2013). Targeted co-delivery of docetaxel and siPlk1 by herceptin-conjugated vitamin E TPGS based immunomicelles. Biomaterials 34, 3411-3421. doi: 10.1016/j.biomaterials.2013.01.009
251. Zhao, Y. (2007). Rational design of light-controllable polymer micelles. Chem. Rec. 7, 286-294. doi: 10.1002/tcr.20127
252. Zhao, Y., Duan, S., Zeng, X., Liu, C., Davies, N. M., Li, B., et al. (2012). Prodrug strategy for PSMA-targeted delivery of TGX-221 to prostate cancer cells. Mol. Pharm. 9, 1705-1716. doi: 10.1021/mp3000309
253. Zhong, Y., Yang, W., Sun, H., Cheng, R., Meng, F., Deng, C., et al. (2013). Ligand-directed reduction-sensitive shell-sheddable biodegradable micelles actively deliver doxorubicin into the nuclei of target cancer cells. Biomacromolecules 14, 3723-3730. doi: 10.1021/bm401098w
254. Zhu, L., Kate, P., and Torchilin, V. P. (2012). Matrix metalloprotease 2-responsive multifunctional liposomal nanocarrier for enhanced tumor targeting. ACS Nano 6, 3491-3498. doi: 10.1021/nn300524f
255. Zhu, L., Perche, F., Wang, T., and Torchilin, V. P. (2014). Matrix metalloproteinase 2-sensitive multifunctional polymeric micelles for tumor-specific co-delivery of siRNA and hydrophobic drugs. Biomaterials 35, 4213-4222. doi: 10.1016/j.biomaterials.2014.01.060
256. Zhu, L., Wang, T., Perche, F., Taigind, A., and Torchilin, V. P. (2013). Enhanced anticancer activity of nanopreparation containing an MMP2-sensitive PEG-drug conjugate and cell-penetrating moiety. Proc. Natl. Acad. Sci. U.S.A. 110, 17047-17052. doi: 10.1073/pnas.1304987110
257. Zou, S., Cao, N., Cheng, D., Zheng, R., Wang, J., Zhu, K., et al. (2012). Enhanced apoptosis of ovarian cancer cells via nanocarrier-mediated codelivery of siRNA and doxorubicin. Int. J. Nanomedicine 7, 3823-3835. doi: 10.2147/IJN.S29328